In pancreatic cancer cells, GLRX3 was increased in spheres compared to adherent cells and was also increased in CD24+/CD44+/ESA+ cells compared to CD24−/CD44−/ESA- cells. Here, GLRX3 is linked to familial pancreatic carcinoma.